Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.

Oncotarget - 28 Jun 2016

Haxho Fiona, Neufeld Ronald J, Szewczuk Myron R

Abstract excerpt

Several of the growth factors and their receptor tyrosine kinases (RTK) such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and insulin are promising candidate targets for cancer therapy. Indeed, tyrosine kinase inhibitors (TKI) have been developed to target these growth factors and their...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinogenesis
Share to Enzyme Activation
Share to Macrophages

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Matrix Metalloproteinase 9

Share to Neoplasm Metastasis

Share to Neuraminidase

Share to Oseltamivir

Share to Receptor Protein-Tyrosine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 27029067
DOI: 10.18632/oncotarget.8396
PMCID: PMC5130050

Genes

EGF
NGF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neuraminidase-1: a novel therapeutic target in multistage tumorigenesis.PMID 27029067Read ↗

A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancerSemantic proximity Read ↗

The epidermal growth factor receptor familySemantic proximity Read ↗

VEGF-A acts via neuropilin-1 to enhance epidermal cancer stem cell survival and formation of aggressive and highly vascularized tumorsSemantic proximity Read ↗

Genetic status of KRAS influences Transforming Growth Factor-beta (TGF-β) signaling: An insight into Neuropilin-1 (NRP1) mediated tumorigenesis.Semantic proximity Read ↗

Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis-New insight and futuristic vision.Semantic proximity Read ↗

Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.Semantic proximity Read ↗

Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasisSemantic proximity Read ↗

Neuropilins Controlling Cancer Therapy ResponsivenessSemantic proximity Read ↗

Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a mediator of multiple physiological and pathological pathways.Semantic proximity Read ↗

The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis.Semantic proximity Read ↗

Hallmarks of cancer: The insulin-like growth factors perspectiveSemantic proximity Read ↗

IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migrationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.